Home

bohužel Dokázat Auto bladder cancer cd73 metastatic marker Sui Okupovat Vylepšit

Cancers | Free Full-Text | Identification of CD73 as a Novel Biomarker  Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic  Responses in Various Cancers
Cancers | Free Full-Text | Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers

Cancers | Free Full-Text | CD73 Overexpression Promotes Progression and  Recurrence of Papillary Thyroid Carcinoma
Cancers | Free Full-Text | CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma

The difference of CD73 expression levels in lung cancer tumor tissue... |  Download Scientific Diagram
The difference of CD73 expression levels in lung cancer tumor tissue... | Download Scientific Diagram

Cancers | Free Full-Text | Increased Extracellular Adenosine in  Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression  through A2AR-Akt-β-Catenin Signaling
Cancers | Free Full-Text | Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling

Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic  challenges, advances and opportunities beyond immune checkpoint -  eBioMedicine
Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint - eBioMedicine

Cancers | Free Full-Text | Urinary Biomarkers in Bladder Cancer: Where Do  We Stand and Potential Role of Extracellular Vesicles
Cancers | Free Full-Text | Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles

Molecular principles of metastasis: a hallmark of cancer revisited | Signal  Transduction and Targeted Therapy
Molecular principles of metastasis: a hallmark of cancer revisited | Signal Transduction and Targeted Therapy

CD73, What a Powerful Therapy Target in Tumor Immune
CD73, What a Powerful Therapy Target in Tumor Immune

Cancers | Free Full-Text | Identification of CD73 as a Novel Biomarker  Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic  Responses in Various Cancers
Cancers | Free Full-Text | Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers

Frontiers | Therapeutic Implications of Tumor Microenvironment in Lung  Cancer: Focus on Immune Checkpoint Blockade
Frontiers | Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade

CD73, What a Powerful Therapy Target in Tumor Immune
CD73, What a Powerful Therapy Target in Tumor Immune

Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors  | PNAS
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors | PNAS

Targeting immunosuppressive adenosine in cancer | Nature Reviews Cancer
Targeting immunosuppressive adenosine in cancer | Nature Reviews Cancer

Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic  challenges, advances and opportunities beyond immune checkpoint -  eBioMedicine
Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint - eBioMedicine

Next steps for clinical translation of adenosine pathway inhibition in  cancer immunotherapy | Journal for ImmunoTherapy of Cancer
Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy | Journal for ImmunoTherapy of Cancer

How to turn up the heat on the cold immune microenvironment of metastatic  prostate cancer | Prostate Cancer and Prostatic Diseases
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer | Prostate Cancer and Prostatic Diseases

Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities: Trends in  Cancer
Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities: Trends in Cancer

The elegant complexity of mammalian ecto-5′-nucleotidase (CD73): Trends in  Cell Biology
The elegant complexity of mammalian ecto-5′-nucleotidase (CD73): Trends in Cell Biology

Frontiers | Immunometabolic Dysfunction of Natural Killer Cells Mediated by  the Hypoxia-CD73 Axis in Solid Tumors
Frontiers | Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors

Cancers | Free Full-Text | The CD73/Ado System—A New Player in RT Induced  Adverse Late Effects
Cancers | Free Full-Text | The CD73/Ado System—A New Player in RT Induced Adverse Late Effects

CD73 expression and activity in serum-derived exosomes. (A) A... | Download  Scientific Diagram
CD73 expression and activity in serum-derived exosomes. (A) A... | Download Scientific Diagram

IJMS | Free Full-Text | Extracellular Vesicles as Biomarkers Carriers in Bladder  Cancer: Diagnosis, Surveillance, and Treatment
IJMS | Free Full-Text | Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment

Targeting CD73 to augment cancer immunotherapy - ScienceDirect
Targeting CD73 to augment cancer immunotherapy - ScienceDirect

Exosome-Mediated Metastasis: From Epithelial–Mesenchymal Transition to  Escape from Immunosurveillance: Trends in Pharmacological Sciences
Exosome-Mediated Metastasis: From Epithelial–Mesenchymal Transition to Escape from Immunosurveillance: Trends in Pharmacological Sciences

Extracellular ATP and adenosine in tumor microenvironment: Roles in  epithelial–mesenchymal transition, cell migration, and invasion - Alvarez -  2022 - Journal of Cellular Physiology - Wiley Online Library
Extracellular ATP and adenosine in tumor microenvironment: Roles in epithelial–mesenchymal transition, cell migration, and invasion - Alvarez - 2022 - Journal of Cellular Physiology - Wiley Online Library

Targeting the CD73-adenosine axis in immuno-oncology - ScienceDirect
Targeting the CD73-adenosine axis in immuno-oncology - ScienceDirect

Frontiers | Targeting the Immunomodulatory CD73/Adenosine System to Improve  the Therapeutic Gain of Radiotherapy
Frontiers | Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy